|
1
|
Di Spigna G, Del Puente A, Covelli B,
Abete E, Varriale E, Salzano S and Postiglione L: Vitamin D
receptor polymorphisms as tool for early screening of severe bone
loss in women patients with rheumatoid arthritis. Eur Rev Med
Pharmacol Sci. 20:4664–4669. 2016.PubMed/NCBI
|
|
2
|
Calabrò A, Caterino AL, Elefante E,
Valentini V, Vitale A, Talarico R, Cantarini L and Frediani B: One
year in review 2016: Novelties in the treatment of rheumatoid
arthritis. Clin Exp Rheumatol. 34:357–372. 2016.PubMed/NCBI
|
|
3
|
Bellucci E, Terenzi R, La Paglia GM,
Gentileschi S, Tripoli A, Tani C and Alunno A: One year in review
2016: Pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol.
34:793–801. 2016.PubMed/NCBI
|
|
4
|
Flurey CA, Hewlett S, Rodham K, White A,
Noddings R and Kirwan J: Men, rheumatoid arthritis, psychosocial
impact and self-management: A narrative review. J Health Psychol.
21:2168–2182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang C, Wang L, Ding Y, Lu X, Zhang G,
Yang J, Zheng H, Wang H, Jiang Y and Xu L: LncRNA structural
characteristics in epigenetic regulation. Int J Mol Sci.
18:26592017. View Article : Google Scholar
|
|
6
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frank S, Aguirre A, Hescheler J and Kurian
L: A lncRNA perspective into (re)building the heart. Front Cell Dev
Biol. 4:1282016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Balik V, Srovnal J, Sulla I, Kalita O,
Foltanova T, Vaverka M, Hrabalek L and Hajduch M: MEG3: A novel
long noncoding potentially tumour-suppressing RNA in meningiomas. J
Neurooncol. 112:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Benetatos L, Voulgaris E and Vartholomatos
G: DLK1-MEG3 imprinted domain microRNAs in cancer biology. Crit Rev
Eukaryot Gene Expr. 22:1–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krause A, Scaletta N, Ji JD and Ivashkiv
LB: Rheumatoid arthritis synoviocyte survival is dependent on
Stat3. J Immunol. 169:6610–6616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deane KD, Demoruelle MK, Kelmenson LB,
Kuhn KA, Norris JM and Holers VM: Genetic and environmental risk
factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol.
31:3–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu H, Hu D, Zhang L and Tang P: Role of
extracellular vesicles in rheumatoid arthritis. Mol Immunol.
93:125–132. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sehgal PB: Paradigm shifts in the cell
biology of STAT signaling. Semin Cell Dev Biol. 19:329–340. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tebbutt NC, Giraud AS, Inglese M, Jenkins
B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, et
al: Reciprocal regulation of gastrointestinal homeostasis by SHP2
and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat
Med. 8:1089–1097. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ranger JJ, Levy DE, Shahalizadeh S,
Hallett M and Muller WJ: Identification of a Stat3-dependent
transcription regulatory network involved in metastatic
progression. Cancer Res. 69:6823–6830. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsumoto S, Müller-Ladner U, Gay RE,
Nishioka K and Gay S: Ultrastructural demonstration of apoptosis,
Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J
Rheumatol. 23:1345–1352. 1996.PubMed/NCBI
|
|
19
|
Yu H and Jove R: The STATs of cancer - new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perlman H, Georganas C, Pagliari LJ, Koch
AE, Haines K III and Pope RM: Bcl-2 expression in synovial
fibroblasts is essential for maintaining mitochondrial homeostasis
and cell viability. J Immunol. 164:5227–5235. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Korb A, Pavenstädt H and Pap T: Cell death
in rheumatoid arthritis. Apoptosis. 14:447–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tolboom TC, van der Helm-Van Mil AH,
Nelissen RG, Breedveld FC, Toes RE and Huizinga TW: Invasiveness of
fibroblast-like synoviocytes is an individual patient
characteristic associated with the rate of joint destruction in
patients with rheumatoid arthritis. Arthritis Rheum. 52:1999–2002.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishiguro N: Cartilage degradation in
rheumatoid arthritis. Clin Calcium. 19:347–354. 2009.(In Japanese).
PubMed/NCBI
|
|
24
|
Eck SM, Blackburn JS, Schmucker AC,
Burrage PS and Brinckerhoff CE: Matrix metalloproteinase and G
protein coupled receptors: Co-conspirators in the pathogenesis of
autoimmune disease and cancer. J Autoimmun. 33:214–221. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kotake S, Nanke Y, Yago T and Yamanaka H:
Serum markers of synovitis and bone metabolism in rheumatoid
arthritis. Clin Calcium. 19:362–371. 2009.(In Japanese). PubMed/NCBI
|
|
26
|
Chen Q, Jin M, Yang F, Zhu J, Xiao Q and
Zhang L: Matrix metalloproteinases: Inflammatory regulators of cell
behaviors in vascular formation and remodeling. Mediators Inflamm.
2013:9283152013. View Article : Google Scholar : PubMed/NCBI
|
